Autori: Leppa Sirpa
Naslov | Longer Term Efficacy and Safety of Subcutaneous Compared with Intravenous Rituximab: Updated Results of the Phase 3 SABRINA Study (Meeting Abstract) |
Autori | Davies Andrew J Mihaljevic Biljana S Mercadal Santiago Mihaylov Georgi Leppa Sirpa Cotting Denise Veenstra Klaas Zharkov Artem Dixon Mark Barrett Martin Macdonald David |
Info | BLOOD, (2016), vol. 128 br. 22, str. - |
Projekat | Takeda Pharmaceutical Company Ltd; |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|